FDA considers a compound to be "licensed for investigation as a different drug" if it is the subject of an Investigational New Drug software (IND) which includes gone into effect. Under FDA’s restrictions (21 CFR 312.2), Except a scientific investigation satisfies the limited standards in that regulation, an IND is https://donovanfvhte.sharebyblog.com/32983300/the-greatest-guide-to-cbd-cannabidiol